[Antifibrinolytic therapy in obstetrics and gynecology]

[Antifibrinolytic therapy in obstetrics and gynecology] Research Abstract Details 

Research Abstract Table of Contents

Jump to the:

[Antifibrinolytic therapy in obstetrics and gynecology] Abstract Text:

W Schild,

[Antifibrinolytic therapy in obstetrics and gynecology] Publishing Authors By Initials

W Schild,

For similar female urogenital diseases and pregnancy complications: pregnancy complications: pregnancy complications, hematologic research abstracts see: female urogenital diseases and pregnancy complications: pregnancy complications: pregnancy complications, hematologic research

PUBMED ID PMID:

MEDLINE DATE:

[Antifibrinolytic therapy in obstetrics and gynecology] Journal Published:

PUBLICATION TYPE: Journal Article

Journal: Gynaecologia. International monthly review of obst

VOLUME: 160

Page Numbers: 39-48

Journal Abbreviation:

ISSN: 0367-5513

DAY: 10

MONTH: 12

YEAR: 1965

[Antifibrinolytic therapy in obstetrics and gynecology] Information

Number of References:

LANGUAGE: ger

NlmUniqueID: 245617

[Antifibrinolytic therapy in obstetrics and gynecology] Keywords Mesh Terms:

KEYWORDS: Pregnancy Complications, Hematologic

MESH TERMS: drug therapy

Chemical & Substance for Abstract: [Antifibrinolytic therapy in obstetrics and gynecology] Information

Substance Name: Aprotinin

Registry Number: 9087-70-1

Grant and Affiliation Information for [Antifibrinolytic therapy in obstetrics and gynecology]

AFFILIATION:

Country: SWITZERLAND

AGENCY:

GRANT:

ACRONYM:

MEDLINETA: Gynaecologia

REFSOURCE:

DATABASENAME:

ACCESSION NUMBER:

Number Hits: 0

Antifibrinolytic therapy in obstetrics and gynecology Related Publications

• (+)-Octen-l-yl-3-acetat aus dem etherischen O1 von Senecio silvaticus.
• Cadmium trapping in an epithelial sodium channel pore mutant.
• Carcinoma in situ of the larynx.
• Clinical advantages of 3.0T MRI over 1.5T.
• Defining the role of hemithorax irradiation for thymomas is difficult.
• Evaluation of 2 whole-brain radiotherapy schedules and prognostic factors for brain metastases in breast cancer patients.
• Fetal adrenal haemorrhage - two-dimensional and three-dimensional imaging.
• Impaired cytotrophoblast cell-cell fusion is associated with reduced Syncytin and increased apoptosis in patients with placental dysfunction.
• Intra-individual comparison of image contrast in SPIO-enhanced liver MRI at 1.5T and 3.0T.
• OP08.07: New specific ultrasound-based weight formula for fetuses with abdominal wall defects.
• OP08.11: Placental volume measurement by 3D ultrasound in the first trimester and prediction of fetal growth restriction.
• P34.02: Macrosomia: a new formula for optimized fetal weight estimation.
• P34.03: New formulae for estimating fetal weight for specific birth weight groups.
• Persistent tetrodotoxin-resistant Na+ currents are activated by prostaglandin E2 via cyclic AMP-dependent pathway in C-type nodose neurons of adult rats.
• Pre-operative staging of breast cancer with breast MRI: One step forward, two steps back?
• Promotion of homologous recombination and genomic stability by RAD51AP1 via RAD51 recombinase enhancement.
• RAD51AP2, a novel vertebrate- and meiotic-specific protein, shares a conserved RAD51-interacting C-terminal domain with RAD51AP1/PIR51.
• Reduction of overall treatment time in patients irradiated for more than three brain metastases.
• Release of histamine by ammonia.
• The experimental evidence for the use of antihistamine drugs in allergic conditions.
• The first score predicting overall survival in patients with metastatic spinal cord compression.
• Theoretical and electrophysiological evidence for axial loading about aortic baroreceptor nerve terminals in rats.
• Three-dimensional volumetry and fetal weight measurement.
• Uber den Alkaloidgehalt des Ziermohns.
• Unmyelinated visceral afferents exhibit frequency dependent action potential broadening while myelinated visceral afferents do not.
• Whole-brain radiotherapy versus stereotactic radiosurgery for patients in recursive partitioning analysis classes 1 and 2 with 1 to 3 brain metastases.
• [Antifibrinolytic therapy in obstetrics and gynecology]
• [Myasthenia gravis pseudoparalytica during pregnancy, the puerperium, and in the newborn.]
• [The effect of sex hormones and vascular processes casued by aging on the ballistocardiogram.]
• pAx and competitive drug antagonism.